Device-Specific Responses to Pacemaker-Mediated Arrhythmia in Patients With Prolonged Ventriculoatrial Conduction: A...

Area of Science:

• Cardiology
• Biomedical Engineering
• Medical Device Technology

Background:

• Pacemaker-mediated tachycardia (PMT) can be difficult to detect and terminate, particularly with prolonged ventriculoatrial conduction (VAC).
• The effectiveness of anti-PMT algorithms and the utility of DDI mode in these scenarios require further investigation.

Purpose of the Study:

• To evaluate the performance of different dual-chamber pacemakers in detecting and terminating PMT during prolonged VAC.
• To assess the behavior of pacemakers in DDI mode, focusing on atrial sensing within the post-ventricular atrial refractory period (PVARP) and atrial pacing adjustments.

Main Methods:

• Five dual-chamber pacemakers (Abbott, BIOTRONIK, Boston Scientific, Medtronic, MicroPort CRM) were tested using an electrophysiological simulator.
• Simulations were conducted with VAC times of 450 ms and 550 ms, assessing PMT detection/termination in DDD mode and atrial sensing/pacing in DDI mode.

Main Results:

• PMT detection varied, with most devices detecting it at 450 ms VAC, but only Abbott terminating it at 550 ms VAC. Atrial sensing within PVARP occurred in most devices at 450 ms VAC, and only BIOTRONIK at 550 ms VAC.
• BIOTRONIK, Boston Scientific, and Medtronic adjusted atrial pacing after sensing within PVARP, unlike Abbott, which led to repetitive ventriculoatrial synchrony.

Conclusions:

• Pacemaker anti-PMT performance differs significantly across manufacturers.
• Devices with longer PVARP and atrial pacing delay algorithms provide better protection against PMT during prolonged VAC.
• Individualized pacemaker selection and programming are crucial for managing pacemaker-mediated arrhythmias.